2013
DOI: 10.1182/blood-2013-05-498311
|View full text |Cite
|
Sign up to set email alerts
|

Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies

Abstract: Recurrent and unpredictable episodes of vaso-occlusion are the hallmark of sickle cell disease. Symptomatic management and prevention of these events using the fetal hemoglobin–reactivating agent hydroxyurea are currently the mainstay of treatment. Discoveries over the past 2 decades have highlighted the important contributions of various cellular and soluble participants in the vaso-occlusive cascade. The role of these elements and the opportunities for therapeutic intervention are summarized in this review.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

4
181
0
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 293 publications
(186 citation statements)
references
References 52 publications
4
181
0
1
Order By: Relevance
“…This finding is consistent with other previous studies which linked white cell and platelet counts with disease severity in sickle cell disease [40,41]. Current patho-physiologic mechanism of vaso-occlusion in sickle cell disease has been found to involve the white cells and platelets as well as the expression of their intercellular adhesion molecules [42,43]. A high platelet count was observed to positively correlate with a tendency to develop avascular necrosis (AVN).…”
Section: Discussionsupporting
confidence: 92%
“…This finding is consistent with other previous studies which linked white cell and platelet counts with disease severity in sickle cell disease [40,41]. Current patho-physiologic mechanism of vaso-occlusion in sickle cell disease has been found to involve the white cells and platelets as well as the expression of their intercellular adhesion molecules [42,43]. A high platelet count was observed to positively correlate with a tendency to develop avascular necrosis (AVN).…”
Section: Discussionsupporting
confidence: 92%
“…We observed adhesion of different RBC subpopulations to FN and LN, reminiscent of RBC subpopulations defined in the literature for vaso-occlusion. 100 Furthermore, although deformable sickle RBCs adhere in higher numbers (especially to LN), nondeformable RBCs display greater adhesion strength, suggesting a critical contribution by both populations to vaso-occlusion.…”
Section: Discussionmentioning
confidence: 97%
“…2 Sickle cell patients homozygous for Hb S (SS disease) or heterozygous for Hb S and either Hb C (SC disease) or β-thalassemia (S–β thalassemia), are all at increased risk for vascular occlusions. 3,4 …”
mentioning
confidence: 99%